$3.49 Billion is the total value of Deep Track Capital, LP's 66 reported holdings in Q1 2024. The portfolio turnover from Q4 2023 to Q1 2024 was 56.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| SWTX | Sell | SPRINGWORKS THERAPEUTICS INC | $171,278,365 | +15.5% | 3,479,853 | -14.4% | 4.91% | -0.9% |
| AMGN | New | AMGEN INC | $156,376,000 | – | 550,000 | +100.0% | 4.48% | – |
| APOGEE THERAPEUTICS INC | $154,393,651 | +137.8% | 2,323,456 | 0.0% | 4.42% | +104.0% | ||
| INSM | Sell | INSMED INC | $129,781,211 | -21.7% | 4,783,679 | -10.6% | 3.72% | -32.9% |
| DYN | Buy | DYNE THERAPEUTICS INC | $129,327,323 | +386.2% | 4,555,383 | +127.8% | 3.70% | +317.1% |
| ALNY | New | ALNYLAM PHARMACEUTICALS INC | $124,388,730 | – | 832,310 | +100.0% | 3.56% | – |
| GH | Buy | GUARDANT HEALTH INC | $123,780,000 | -8.5% | 6,000,000 | +20.0% | 3.55% | -21.5% |
| ARGX | ARGENX SEsponsored adr | $118,116,000 | +3.5% | 300,000 | 0.0% | 3.38% | -11.2% | |
| NTLA | Buy | INTELLIA THERAPEUTICS INC | $115,838,668 | +68.9% | 4,210,784 | +87.1% | 3.32% | +44.8% |
| OCUL | Buy | OCULAR THERAPEUTIX INC | $115,765,286 | +181.2% | 12,721,460 | +37.8% | 3.32% | +141.2% |
| DVAX | Buy | DYNAVAX TECHNOLOGIES CORP | $113,448,001 | +14.4% | 9,141,660 | +28.9% | 3.25% | -1.9% |
| AXSM | Buy | AXSOME THERAPEUTICS INC | $104,116,736 | +30.8% | 1,304,721 | +30.5% | 2.98% | +12.2% |
| ITCI | Sell | INTRA-CELLULAR THERAPIES INC | $103,800,000 | -27.5% | 1,500,000 | -25.0% | 2.97% | -37.9% |
| GERN | Buy | GERON CORP | $100,669,566 | +61.3% | 30,505,929 | +3.1% | 2.88% | +38.3% |
| AUTL | Buy | AUTOLUS THERAPEUTICS PLCspon ads | $97,436,457 | +27.5% | 15,272,172 | +28.7% | 2.79% | +9.3% |
| FDMT | Buy | 4D MOLECULAR THERAPEUTICS IN | $96,677,673 | +108.9% | 3,034,453 | +32.8% | 2.77% | +79.1% |
| ALKS | Sell | ALKERMES PLC | $94,745,000 | -14.6% | 3,500,000 | -12.5% | 2.71% | -26.8% |
| BCYC | BICYCLE THERAPEUTICS PLCsponsored ads | $86,913,599 | +37.7% | 3,490,506 | 0.0% | 2.49% | +18.1% | |
| PLRX | PLIANT THERAPEUTICS INC | $85,675,000 | -17.7% | 5,750,000 | 0.0% | 2.45% | -29.4% | |
| New | MIND MEDICINE MINDMED INC | $62,666,670 | – | 6,666,667 | +100.0% | 1.80% | – | |
| ABIVAX SAsponsored ads | $61,453,363 | +33.6% | 4,297,438 | 0.0% | 1.76% | +14.6% | ||
| VRDN | Sell | VIRIDIAN THERAPEUTICS INC | $60,515,488 | -23.5% | 3,456,053 | -4.8% | 1.73% | -34.4% |
| IONS | Buy | IONIS PHARMACEUTICALS INC | $59,540,141 | -5.8% | 1,373,475 | +10.0% | 1.70% | -19.2% |
| APLS | New | APELLIS PHARMACEUTICALS INC | $58,780,000 | – | 1,000,000 | +100.0% | 1.68% | – |
| ANIP | Buy | ANI PHARMACEUTICALS INC | $56,824,929 | +71.8% | 822,001 | +37.0% | 1.63% | +47.3% |
| TVTX | TRAVERE THERAPEUTICS INC | $56,822,700 | -14.2% | 7,370,000 | 0.0% | 1.63% | -26.4% | |
| VRNA | VERONA PHARMA PLCsponsored ads | $51,285,507 | -19.1% | 3,187,415 | 0.0% | 1.47% | -30.6% | |
| KYMR | New | KYMERA THERAPEUTICS INC | $50,742,289 | – | 1,262,246 | +100.0% | 1.45% | – |
| New | INVIVYD INC | $48,635,480 | – | 10,953,937 | +100.0% | 1.39% | – | |
| Sell | SPYRE THERAPEUTICS INC | $46,025,021 | +9.5% | 1,213,420 | -37.9% | 1.32% | -6.1% | |
| NRIX | NURIX THERAPEUTICS INC | $44,068,101 | +42.4% | 2,997,830 | 0.0% | 1.26% | +22.2% | |
| Sell | HILLEVAX INC | $42,780,010 | -8.1% | 2,572,460 | -11.3% | 1.22% | -21.2% | |
| EDIT | Buy | EDITAS MEDICINE INC | $41,012,492 | -26.0% | 5,527,290 | +1.0% | 1.18% | -36.6% |
| FATE | New | FATE THERAPEUTICS INC | $40,902,935 | – | 5,572,607 | +100.0% | 1.17% | – |
| TERN | TERNS PHARMACEUTICALS INC | $40,016,000 | +1.1% | 6,100,000 | 0.0% | 1.15% | -13.3% | |
| New | ENGENE HOLDINGS INC | $38,137,500 | – | 2,250,000 | +100.0% | 1.09% | – | |
| Sell | TOURMALINE BIO INC | $36,534,660 | -23.1% | 1,595,400 | -12.1% | 1.05% | -34.1% | |
| OLMA | Buy | OLEMA PHARMACEUTICALS INC | $36,511,743 | +34.8% | 3,225,419 | +67.0% | 1.05% | +15.6% |
| SLN | Sell | SILENCE THERAPEUTICS PLCads | $35,507,830 | +4.7% | 1,643,881 | -15.8% | 1.02% | -10.2% |
| PACB | PACIFIC BIOSCIENCES CALIF IN | $26,250,000 | -61.8% | 7,000,000 | 0.0% | 0.75% | -67.2% | |
| CLXPF | New | CYBIN INC | $24,040,698 | – | 58,139,535 | +100.0% | 0.69% | – |
| ALEC | New | ALECTOR INC | $22,691,704 | – | 3,769,386 | +100.0% | 0.65% | – |
| Sell | NUVALENT INC | $20,613,106 | -37.8% | 274,512 | -39.0% | 0.59% | -46.7% | |
| AGEN | AGENUS INC | $18,384,573 | -29.9% | 31,697,539 | 0.0% | 0.53% | -39.8% | |
| New | PYXIS ONCOLOGY INC | $17,824,266 | – | 4,184,100 | +100.0% | 0.51% | – | |
| NKTR | NEKTAR THERAPEUTICS | $17,189,280 | +65.3% | 18,400,000 | 0.0% | 0.49% | +41.8% | |
| IMVT | Sell | IMMUNOVANT INC | $15,940,203 | -62.2% | 493,352 | -50.7% | 0.46% | -67.5% |
| New | NEUMORA THERAPEUTICS INC. | $13,750,000 | – | 1,000,000 | +100.0% | 0.39% | – | |
| RPTX | Sell | REPARE THERAPEUTICS INC | $12,643,260 | -42.1% | 2,684,344 | -10.3% | 0.36% | -50.4% |
| ITCI | New | INTRA-CELLULAR THERAPIES INCput | $12,137,680 | – | 175,400 | +100.0% | 0.35% | – |
| SRRK | Sell | SCHOLAR ROCK HLDG CORP | $12,076,800 | -36.5% | 680,000 | -32.8% | 0.35% | -45.5% |
| ANAB | Sell | ANAPTYSBIO INC | $11,923,259 | -72.7% | 529,452 | -74.0% | 0.34% | -76.5% |
| New | REGULUS THERAPEUTICS INC | $9,407,710 | – | 3,266,566 | +100.0% | 0.27% | – | |
| New | ALTO NEUROSCIENCE INC | $9,210,000 | – | 600,000 | +100.0% | 0.26% | – | |
| RARE | New | ULTRAGENYX PHARMACEUTICAL IN | $7,833,835 | – | 167,784 | +100.0% | 0.22% | – |
| ZURA BIO LTD | $6,484,110 | -45.0% | 2,523,000 | 0.0% | 0.19% | -52.7% | ||
| ALLK | Buy | ALLAKOS INC | $6,300,000 | -8.1% | 5,000,000 | +99.1% | 0.18% | -21.4% |
| ALGS | ALIGOS THERAPEUTICS INC | $5,980,715 | +47.6% | 6,102,770 | 0.0% | 0.17% | +26.7% | |
| RLMD | Sell | RELMADA THERAPEUTICS INC | $5,766,158 | -31.9% | 1,240,034 | -39.3% | 0.16% | -41.7% |
| VIGIL NEUROSCIENCE INC | $5,438,715 | +0.9% | 1,594,931 | 0.0% | 0.16% | -13.3% | ||
| New | METAGENOMI INC | $4,918,748 | – | 466,232 | +100.0% | 0.14% | – | |
| SYROS PHARMACEUTICALS INC | $4,432,395 | -31.3% | 828,485 | 0.0% | 0.13% | -41.2% | ||
| MRSN | New | MERSANA THERAPEUTICS INC | $2,596,940 | – | 579,674 | +100.0% | 0.07% | – |
| New | PRIME MEDICINE INC | $2,126,012 | – | 303,716 | +100.0% | 0.06% | – | |
| COGT | New | COGENT BIOSCIENCES INC | $2,123,520 | – | 316,000 | +100.0% | 0.06% | – |
| Sell | STRUCTURE THERAPEUTICS INCsponsored ads | $1,720,272 | -85.9% | 40,137 | -86.6% | 0.05% | -88.0% | |
| GHRS | Exit | GH RESEARCH PLCordinary shares | $0 | – | -499,400 | -100.0% | -0.10% | – |
| JAZZ | Exit | JAZZ PHARMACEUTICALS PLC | $0 | – | -48,280 | -100.0% | -0.20% | – |
| PTGX | Exit | PROTAGONIST THERAPEUTICS INC | $0 | – | -275,201 | -100.0% | -0.21% | – |
| PRTA | Exit | PROTHENA CORP PLCput | $0 | – | -250,000 | -100.0% | -0.30% | – |
| PRTA | Exit | PROTHENA CORP PLCcall | $0 | – | -500,000 | -100.0% | -0.61% | – |
| AGIO | Exit | AGIOS PHARMACEUTICALS INC | $0 | – | -1,062,881 | -100.0% | -0.79% | – |
| CYTK | Exit | CYTOKINETICS INC | $0 | – | -288,949 | -100.0% | -0.81% | – |
| EWTX | Exit | EDGEWISE THERAPEUTICS INC | $0 | – | -2,537,176 | -100.0% | -0.93% | – |
| Exit | ORCHARD THERAPEUTICS PLCspon ads new | $0 | – | -2,041,670 | -100.0% | -1.12% | – | |
| Exit | ARCELLX INC | $0 | – | -725,145 | -100.0% | -1.34% | – | |
| RAPT | Exit | RAPT THERAPEUTICS INC | $0 | – | -1,793,966 | -100.0% | -1.49% | – |
| SRPT | Exit | SAREPTA THERAPEUTICS INC | $0 | – | -500,000 | -100.0% | -1.61% | – |
| Exit | AMBRX BIOPHARMA INC | $0 | – | -3,710,412 | -100.0% | -1.76% | – | |
| CYTK | Exit | CYTOKINETICS INCcall | $0 | – | -1,347,300 | -100.0% | -3.76% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2024-05-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| TRAVERE THERAPEUTICS INC | 11 | Q2 2024 | 5.7% |
| IMMUNOVANT INC | 11 | Q2 2024 | 7.2% |
| BICYCLE THERAPEUTICS PLC | 11 | Q2 2024 | 5.2% |
| 4D MOLECULAR THERAPEUTICS IN | 11 | Q2 2024 | 2.9% |
| DYNE THERAPEUTICS INC | 11 | Q2 2024 | 4.2% |
| VIRIDIAN THERAPEUTICS INC | 11 | Q2 2024 | 2.6% |
| REPARE THERAPEUTICS INC | 11 | Q2 2024 | 3.1% |
| SILENCE THERAPEUTICS PLC | 11 | Q2 2024 | 1.6% |
| VIGIL NEUROSCIENCE INC | 10 | Q2 2024 | 1.1% |
| RELMADA THERAPEUTICS INC | 10 | Q2 2024 | 0.8% |
View Deep Track Capital, LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Context Therapeutics Inc. | May 10, 2024 | 7,419,355 | 9.9% |
| INOVIO PHARMACEUTICALS, INC. | April 26, 2024 | 2,593,822 | 10.0% |
| Korro Bio, Inc. | April 26, 2024 | 714,285 | 7.7% |
| Zura Bio Ltd | April 22, 2024 | 6,216,327 | 9.3% |
| Guardant Health, Inc. | April 12, 2024 | 7,000,000 | 5.8% |
| Avalo Therapeutics, Inc. | April 05, 2024 | 114,775 | 10.0% |
| CYBIN INC. | March 22, 2024 | 58,139,535 | 7.6% |
| Olema Pharmaceuticals, Inc. | March 22, 2024 | 3,040,248 | 5.4% |
| Regulus Therapeutics Inc. | March 22, 2024 | 6,888,424 | 10.0% |
| Mind Medicine (MindMed) Inc. | March 15, 2024 | 6,666,667 | 9.5% |
View Deep Track Capital, LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13D | 2024-09-16 |
| N-PX | 2024-08-15 |
| 13F-HR | 2024-08-14 |
| SC 13G | 2024-07-12 |
| SC 13G | 2024-07-02 |
| 13F-HR | 2024-05-15 |
| 4 | 2024-05-13 |
| SC 13G | 2024-05-10 |
| SC 13G | 2024-04-26 |
| SC 13G | 2024-04-26 |
View Deep Track Capital, LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.